Drug makers' "entire focus globally is going to be cost-effectiveness," said Sujay Shetty, India pharmaceutical leader at PricewaterhouseCoopers. Government policy makers from the United States and Europe are concentrating on lowering health care costs, and drug companies that once dismissed generic drugs are now getting into the market, he said.
In comparison with studies sponsored by nonprofit organisations, industry-sponsored studies were 1.9 times more likely to be cost-minimisation analyses, and 2.5 times less likely to be cost-effectiveness analyses.
Compared to studies sponsored by nonprofit organisations, industry-sponsored studies were 2.56 (lower 99% CI=1.28, therefore >1.00) times more likely to be cost-minimisation analyses and 0.60 (higher 99% CI=0.92, or <1.00) times less likely to be cost-effectiveness analyses.
The key issues to be considered are cost-effectiveness, added complexity, additional benefits, reliability, and efficiency potential.
Health insurance companies may still be reluctant to finance GRT although it's cost-effectiveness has been documented in a few countries.
The economic analysis is expected to be a cost-effectiveness analysis with maternal health as effectiveness.
As we anticipate an improvement of between maternal outcomes after induction of labour the economic analysis is expected to be a cost-effectiveness analysis.
Only one of the 78 studies (1.3%) was considered to be a cost effectiveness study [ 33].
The final worksheets present results and allow effect data to be entered and cost-effectiveness results to be calculated.
Investments are likely to be driven by cost-effectiveness, regulatory mandates, consumer demand and public interest.
A sample size this small proved to be unsuitable for cost-effectiveness analysis and is a limitation of the research study.
